Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamic-oxaloacetic transaminase 2 pseudogene 1 (GOT2P1) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a normal gene but typically non-functional; it does not encode a biologically active protein and is not expected to possess enzymatic or signaling function. While the protein-coding gene GOT2 plays a critical role in amino acid metabolism and mitochondrial function, GOT2P1 represents only a related, non-coding, and likely non-functional genomic element; consequently, GOT2P1 is not considered a therapeutic target, has no established biological function, and is not associated with human disease or drug interactions. **Supporting details and clarification:** - **Canonical name standardization**: The consistently used scientific name for this pseudogene is "Glutamic-oxaloacetic transaminase 2 pseudogene 1". - **Is this a therapeutic target?** Pseudogenes lack the biological activity, ligand-binding capacity, or enzyme function required to be "targets" in drug discovery or therapy. - **Aliases**: Multiple names listed are all variants or descriptors of the same pseudogene (e.g., GOT2 pseudogene 1, GOT2L1, etc.). - **Biological and disease roles**: No documented or established biological function or implication in disease for this pseudogene. It is annotated as a pseudogene and not experimentally linked to pathophysiology. - **No drugs or mechanism of action, biomarker potential, or safety considerations** are relevant for this pseudogene. - **Related information**: The functional enzyme is encoded by the GOT2 gene, not by this pseudogene. **Summary**: Glutamic-oxaloacetic transaminase 2 pseudogene 1 (GOT2P1) is a non-coding genomic sequence resembling the functional GOT2 enzyme gene but lacks protein-coding and functional activity. It is not considered a therapeutic target, has no proven biological function, and is not involved in disease or drug response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamic-oxaloacetic transaminase 2 pseudogene 1 (GOT2P1).